Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Sydow

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|February 3, 2004
Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-toleranceKarsten Sydow, Andreas Daiber, Matthias Oelze, et al.
International Journal of Cardiology|February 11, 2014
Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyAnne Funke-Kaiser, Kristy Mann, David Colquhoun, et al.
Transplantation|March 25, 2008
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimusLuciano Potena, William F Fearon, Karsten Sydow, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 7, 2016
Biomarker response and therapy prediction in renal denervation therapy - the role of MR-proadrenomedullin in a multicenter approachJohannes Tobias Neumann, Marius Schwerg, Oliver Dörr, et al.
Free Radical Biology & Medicine|July 5, 2005
Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4Maria C Wendt, Andreas Daiber, Andrei L Kleschyov, et al.
Pharmacological Research|August 12, 2009
Extensive characterization of the human DDAH1 transgenic miceEdzard Schwedhelm, Eike-Christin von Leitner, Dorothee Atzler, et al.
BMC Gastroenterology|October 8, 2011
The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS)Daniel Benten, Julian Schulze zur Wiesch, Karsten Sydow, et al.
Clinical Therapeutics|November 7, 2017
Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort StudyChristoph Waldeyer, Moritz Seiffert, Nils Staebe, et al.
European Journal of Heart Failure|October 7, 2016
Concomitant implantation of Impella<sup>®</sup> on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shockFederico Pappalardo, Christian Schulte, Marina Pieri, et al.
Plos One|October 31, 2012
Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertensionKarsten Sydow, Christine Schmitz, Eike-Christin von Leitner, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|February 3, 2004
Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-toleranceKarsten Sydow, Andreas Daiber, Matthias Oelze, et al.
International Journal of Cardiology|February 11, 2014
Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyAnne Funke-Kaiser, Kristy Mann, David Colquhoun, et al.
Transplantation|March 25, 2008
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimusLuciano Potena, William F Fearon, Karsten Sydow, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 7, 2016
Biomarker response and therapy prediction in renal denervation therapy - the role of MR-proadrenomedullin in a multicenter approachJohannes Tobias Neumann, Marius Schwerg, Oliver Dörr, et al.
Free Radical Biology & Medicine|July 5, 2005
Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4Maria C Wendt, Andreas Daiber, Andrei L Kleschyov, et al.
Pharmacological Research|August 12, 2009
Extensive characterization of the human DDAH1 transgenic miceEdzard Schwedhelm, Eike-Christin von Leitner, Dorothee Atzler, et al.
BMC Gastroenterology|October 8, 2011
The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS)Daniel Benten, Julian Schulze zur Wiesch, Karsten Sydow, et al.
Clinical Therapeutics|November 7, 2017
Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort StudyChristoph Waldeyer, Moritz Seiffert, Nils Staebe, et al.
European Journal of Heart Failure|October 7, 2016
Concomitant implantation of Impella<sup>®</sup> on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shockFederico Pappalardo, Christian Schulte, Marina Pieri, et al.
Plos One|October 31, 2012
Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertensionKarsten Sydow, Christine Schmitz, Eike-Christin von Leitner, et al.
Pageof 6